Search by Drug Name or NDC
NDC 24208-0486-10 Dorzolamide Hydrochloride and Timolol Maleate 20; 5 mg/mL; mg/mL Details
Dorzolamide Hydrochloride and Timolol Maleate 20; 5 mg/mL; mg/mL
Dorzolamide Hydrochloride and Timolol Maleate is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE.
MedlinePlus Drug Summary
The combination of dorzolamide and timolol is used to treat eye conditions, including glaucoma and ocular hypertension, in which increased pressure can lead to a gradual loss of vision. Dorzolamide and timolol is used for patients whose eye condition has not responded to another medication. Dorzolamide is in a class of medications called topical carbonic anhydrase inhibitors. Timolol is in a class of medications called topical beta blockers. Dorzolamide and timolol lowers pressure in the eye by decreasing the production of natural fluids in the eye.
Related Packages: 24208-0486-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dorzolamide and Timolol Ophthalmic
Product Information
| NDC | 24208-0486 |
|---|---|
| Product ID | 24208-486_07b50c6a-8d83-47f6-9f52-d40b199a2059 |
| Associated GPIs | 86259902202020 |
| GCN Sequence Number | 039531 |
| GCN Sequence Number Description | dorzolamide HCl/timolol maleat DROPS 22.3-6.8/1 OPHTHALMIC |
| HIC3 | Q6G |
| HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
| GCN | 95919 |
| HICL Sequence Number | 018269 |
| HICL Sequence Number Description | DORZOLAMIDE HCL/TIMOLOL MALEATE |
| Brand/Generic | Generic |
| Proprietary Name | Dorzolamide Hydrochloride and Timolol Maleate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dorzolamide Hydrochloride and Timolol Maleate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 20; 5 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE |
| Labeler Name | Bausch & Lomb Incorporated |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090037 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24208-0486-10 (24208048610)
| NDC Package Code | 24208-486-10 |
|---|---|
| Billing NDC | 24208048610 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (24208-486-10) / 10 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2009-07-14 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.04286 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | DORZOLAMIDE-TIMOLOL EYE DROPS |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |